Coronary Artery Disease

Impact of platelet glycoprotein IIb/IIIa receptor inhibitors on outcomes of diabetic patients undergoing percutaneous coronary interventions using sirolimus-eluting stents

  1. Eugenia Nikolsky1,
  2. David R. Holmes2,
  3. Roxana Mehran1,*,
  4. George Dangas1,
  5. Erick Schampaert3,
  6. Marie-Claude Morice4,
  7. Joachim Schofer5,
  8. J. Eduardo Sousa6,
  9. Martin Fahy1,
  10. Yingbo Na1,
  11. Dennis J. Donohoe7,†,
  12. Jeffrey W. Moses1,
  13. Martin B. Leon1

Article first published online: 22 MAY 2008

DOI: 10.1002/ccd.21548

Issue

Catheterization and Cardiovascular Interventions

Catheterization and Cardiovascular Interventions

Volume 71, Issue 7, pages 896–906, 1 June 2008

Additional Information

How to Cite

Nikolsky, E., Holmes, D. R., Mehran, R., Dangas, G., Schampaert, E., Morice, M.-C., Schofer, J., Sousa, J. E., Fahy, M., Na, Y., Donohoe, D. J., Moses, J. W. and Leon, M. B. (2008), Impact of platelet glycoprotein IIb/IIIa receptor inhibitors on outcomes of diabetic patients undergoing percutaneous coronary interventions using sirolimus-eluting stents. Cathet. Cardiovasc. Intervent., 71: 896–906. doi: 10.1002/ccd.21548

Author Information

  1. 1

    Columbia University Medical Center, Center for Interventional Vascular Therapy and the Cardiovascular Research Foundation, New York, NY, USA

  2. 2

    Mayo Clinic College of Medicine, Rochester, MN, USA

  3. 3

    Hopital Sacre-Coeur de Montreal, Montreal, PQ, Canada

  4. 4

    Institut Cardiovasculaire Paris Sud, Massy, France

  5. 5

    Centre for Cardiology and Vascular Intervention, Hamburg, Germany

  6. 6

    Institute Dante Pazzanese, São Paulo, Brazil

  7. 7

    Cordis Corporation, Warren, NJ, USA

  1. †

    Dr. Donohoe is a full-time employee of Johnson & Johnson. Dr. Moses owns common stock in and has served as a consultant to and speaker for Johnson & Johnson. Dr. Leon owns equity in, has received research grants from, and serves as a consultant to Johnson & Johnson.

*Columbia University Medical Center, The Cardiovascular Research Foundation, 55 E. 59th St., 6th Floor, New York City, NY 10022

Publication History

  1. Issue published online: 22 MAY 2008
  2. Article first published online: 22 MAY 2008
  3. Manuscript Accepted: 26 JAN 2008
  4. Manuscript Received: 12 SEP 2007

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (188K)

Options for accessing this content:

  • If you have access to this content through a society membership, please first log in to your society website.
  • If you would like institutional access to this content, please recommend the title to your librarian.
  • Login via Athens http://onlinelibrary.wiley.com/athens or other institutional login options http://onlinelibrary.wiley.com/login-options .
  • You can purchase online access to this Article for a 24-hour period (price varies by title)
    • If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
    • New Users: Please register, then proceed to purchase the article.

Please register to:

  • Save publications, articles and searches
  • Get email alerts
  • Get all the benefits mentioned below!

Register now >

View Full Article (HTML) Get PDF (188K)